Unclear Intake Ownership
When no one owns the first documented action, incoming referrals can remain unassigned or move forward without a consistent status. The operating model should define ownership, response expectations, and escalation.
Clinical trial enrollment operations is the connected operating model for intake, follow-up, preliminary prescreening support, documentation, escalation, coordinator capacity, and handoff after referral generation and before informed consent.
The research site retains clinical interpretation, formal screening, eligibility decisions, informed consent, protocol oversight, investigator responsibility, and randomization decisions.
Clinical trial enrollment operations support is the operating framework that connects new referrals with authorized site review. It defines who owns the next action, how candidate status is documented, when follow-up or escalation occurs, and what information accompanies a handoff.
Patient recruitment creates awareness, inquiries, and referrals. Enrollment operations begins when that interest enters the site's process and organizes ownership, contact status, next actions, escalation, and handoff. The connected framework includes clinical trial intake, preliminary prescreening, coordinator-capacity planning, and measurement of where referrals stop progressing.
This page explains the operating category. Hands-on support executes approved operational activities through Consent2Randomize's hands-on intake and preliminary prescreening support. Organizations that need current-state assessment, recommendations, process design, and implementation planning can explore clinical trial enrollment operations consulting. The research site retains clinical and protocol authority in either model.
CROs, sponsors, site networks, and SMOs coordinating defined support across selected research sites can review site enrollment support engagement models.

These gaps make referral ownership, workload, and next actions harder to see before authorized site review.
When no one owns the first documented action, incoming referrals can remain unassigned or move forward without a consistent status. The operating model should define ownership, response expectations, and escalation.
When coordinators absorb intake, contact tracking, and missing-information follow-up alongside clinical responsibilities, leaders have less visibility into workload and where additional operational support is needed.
If teams use different labels for new, contacted, pending, escalated, and ready for site review, referral activity becomes difficult to compare. Shared status definitions create a common operational record without making an eligibility determination.
Handoffs without candidate-reported information, contact history, unresolved items, or a clear next action create avoidable reconstruction work for authorized site personnel.
Operational structure supports the pathway; clinical authority remains with the research site
Specify who receives each referral, which contact and source fields are required, how missing information is handled, and when the record moves to the next stage.
Use site-approved preliminary questions to collect candidate-reported information, then route unresolved clinical or protocol issues to authorized site personnel. The research site determines eligibility.
Define permitted channels, attempt documentation, status labels, next-action ownership, and escalation points so the team can see what has happened and what remains open.
Provide the research site with the agreed intake record, candidate-reported responses, contact history, scheduling context where permitted, unresolved items, and a documented next action.
Choose the Right Type of Support
Use an alignment call to discuss whether your organization needs an operating-framework assessment or recurring hands-on execution support.
Schedule a CallProprietary Framework
The C2R Enrollment Pathway Framework™ maps the operational pathway from initial candidate contact through site-controlled study entry. Consent2Randomize supports Intake, Preliminary Prescreening, and Site Handoff through site-approved workflows. The research site retains protocol interpretation, clinical judgment, formal screening, final eligibility decisions, informed-consent discussion and documentation, investigator oversight, screening procedures, and randomization decisions.
Referral
A referral, patient inquiry, or expression of interest reaches the research site, and initial contact information is received.
Intake
Candidate-reported information is collected through a site-approved intake workflow, with missing items documented.
C2R SupportPreliminary Prescreening
Responses to site-approved preliminary questions are documented, and unresolved items are identified for authorized site review.
C2R SupportSite Handoff
An organized record, documented open items, and appointment-preparation details are transferred to authorized research-site personnel.
C2R SupportSite Review
Authorized site personnel review the organized record, resolve open items, and determine the appropriate next step.
Consent and Screening
The research site conducts informed consent and formal protocol screening in the order required by the protocol, IRB or IEC approvals, and applicable requirements.
Randomization
The research site makes final eligibility and randomization decisions under investigator oversight.
C2R-supported stages focus on administrative consistency, candidate follow-up, documentation, and organized handoff. They do not include protocol interpretation, formal screening, eligibility decisions, informed consent, or randomization.
Pillar Topics
Tools & Resources
Interactive tools, assessments, and calculators directly relevant to this enrollment topic.
Common questions about clinical trial enrollment operations and how structured processes support research sites.
Resources
Related Resources
If your organization needs clearer ownership, status visibility, escalation, or handoffs, an alignment call can help define the appropriate next step.